Pharmaceutical company Actavis has acquired 100% of the company Fako Ilaçlari AS. Actavis Group announced today it had bought the last 11% of shares for USD 20.4 million. In December 2003 Actavis snared 89% of the shares ... More

Bulgarian drug maker Sopharma to place 5 mln euro bond.

Sofia-based drug maker Sopharma will issue a 5 mln euro bond after a decision to this end was taken by the shareholders on Tuesday, January 24. The 1,000 euro bonds will bear an interest rate equal to the 6-month EURIBOR+300 ... More

Zentiva pays eur 37 m for another 23.9 pc in Sicomed

Czech pharmaceutical producer Zentiva took over almost half of the Sicomed stock subject to the public take-over offer, its total stake in the Romanian company reaching 75 per cent, according to data reported to the BSE. The ... More

Forever Living Products doubles business

Forever Living Products, a company that sells cosmetics and nutrition products, registered a 20.5 million euros turnover in 2005, which is double compared to the 2004 figures, daily Ziarul Financiar reports. General manager ... More

New sports center opens in Sofia

The 4 mln euro spa center Dream opened for business on Sofia's ring road on Tue, Jan 10. The 4,000 sq m wellness center offers a range of sports facilities and beauty treatments. The investor in the project, Sit 97, has earmarked ... More

Export of Hemofarm reached amount of €63m

Hemofarm Concern confirmed its leading position in domestic pharmaceutical industry with its operations in 2005. It is also the biggest exporter of medicines in Serbia. This year, Hemofarm produced 170m packs of medicines, which ... More

Hemofarm hopes to obtain US FDA certificate in 2006

Vrsac-based drug maker Hemofarm expects to obtain a certificate from the US Food and Drugs Administration (FDA), which will enable the company to launch exports to North America, according to Hemofarm President Miodrag Babic. The ... More

Over €3m for development programs of "Zdravlje"

Leskovac-based pharmaceutical-chemical industry "Zdravlje", which operates as part of "Actavis group" from Iceland after privatization, plans to invest over €3m in development projects in 2006. According to the sales ... More

Subsidiaries of foreign drug makers to swarm Bulgarian market

A host of the world's biggest pharmaceutical companies are in the process of registering subsidiaries in Bulgaria in a bid to gain greater independence from the local wholesale distributors and position themselves ahead of the ... More

Jugoremedija, Nini join race for drug firm Srbolek

Pharmaceutical company Srbolek’s stock jumped 20% in trading on the Belgrade Stock Exchange (BSE) after drug firms Jugoremedija and Nini, which have the same owner, bought around 15% of the company on the bourse in the ... More

Bulgarian drug maker Sopharma to open new warehouse in Sofia

Sopharma, the Sofia-based pharmaceuticals company, will open a new storage facility in Sofia within days. The new 9,000 sq m warehouse, sited in the capital's Iliyantsi borough, can accommodate 6,000 palettes. The facility will ... More

Drug retailer Ceiba to pop up in more hypermarkets

Ceiba, the Bulgarian drug store chain, said it will open outlets in the local hypermarkets of Lithuanian retailer VP Market. Ceiba, which operates a network of 68 stand-alone pharmacies, has already been welcomed into five Metro ... More

Bulgarian drug maker Sopharma to buy Serbia's Srbolek

Local pharmaceutical company Sopharma has submitted an offer to the Serbian securities commission for the purchase of 50% of drug maker Srbolek, said Boris Borisov, the investor liaison of the Bulgarian company. Under Serbian ... More

Spa catalogue

Nine Bulgarian companies were represented at the Bulgarian stand at the Leisure 2005 exhibition in Moscow. Apart from preparations for the winter season, the exhibition focused on spa tourism. Tour operator Solvex, taking part ... More

Czechs buy local drug-maker

Romania's pharmaceutical sector once again showed itself to be an attractive investment with Czech-based drug maker, Zentiva, agreeing last week an estimated 200 million USD for one of the nation's biggest generic drugs firm, ... More

Sopharma to acquire stake in biopharmengineering AD

A 51.34% stake in Biopharmengineering AD is going to be acquired by Sopharma a pharmaceutical industry based in Sofia. A preliminary agreement has already been signed for that purpose. Biopharmengineering AD is a Sliven-based ... More